Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1884

1.

A mitochondrial delivery system using liposome-based nanocarriers that target myoblast cells.

Katayama T, Kinugawa S, Takada S, Furihata T, Fukushima A, Yokota T, Anzai T, Hibino M, Harashima H, Yamada Y.

Mitochondrion. 2019 Jul 18. pii: S1567-7249(18)30266-6. doi: 10.1016/j.mito.2019.07.005. [Epub ahead of print]

PMID:
31326598
2.

Clinical background factors affecting outcomes of Helicobacter pylori eradication therapy in primary care.

Yokota N, Ae R, Amenomori M, Kitagawa K, Nakamura T, Yokota T, Masato K, Sasahara T, Matsubara Y, Kosami K, Nakamura Y.

J Gen Fam Med. 2019 Apr 10;20(4):139-145. doi: 10.1002/jgf2.245. eCollection 2019 Jul.

3.

Safety of tapering tacrolimus dose in patients with well-controlled anti-acetylcholine receptor antibody-positive myasthenia gravis.

Nishida Y, Takahashi YK, Kanai T, Nose Y, Ishibashi S, Sanjo N, Uzawa A, Oda F, Ozawa Y, Kuwabara S, Noguchi E, Suzuki S, Nakahara J, Suzuki N, Ogawa T, Yokoyama K, Hattori N, Konno S, Fujioka T, Kawaguchi N, Hatanaka Y, Sonoo M, Kaneko J, Ogino M, Nishiyama K, Nomura K, Yokota T.

Eur J Neurol. 2019 Jul 15. doi: 10.1111/ene.14039. [Epub ahead of print]

PMID:
31309642
4.

Current understanding and treatment of cardiac and skeletal muscle pathology in laminin-α2 chain-deficient congenital muscular dystrophy.

Nguyen Q, Lim KRQ, Yokota T.

Appl Clin Genet. 2019 Jul 3;12:113-130. doi: 10.2147/TACG.S187481. eCollection 2019.

5.

Olivary hypertrophy improved by steroid treatment: Two case reports with unique presentations.

Ohara M, Sanjo N, Hattori T, Oyama J, Hamada M, Ozaki K, Yokota T.

J Neuroimmunol. 2019 Jul 5;334:577003. doi: 10.1016/j.jneuroim.2019.577003. [Epub ahead of print]

PMID:
31306854
6.

Three-dimensional surface models of autopsied human brains constructed from multiple photographs by photogrammetry.

Shintaku H, Yamaguchi M, Toru S, Kitagawa M, Hirokawa K, Yokota T, Uchihara T.

PLoS One. 2019 Jul 10;14(7):e0219619. doi: 10.1371/journal.pone.0219619. eCollection 2019.

7.

Robust 3D image reconstruction of pancreatic cancer tumors from histopathological images with different stains and its quantitative performance evaluation.

Kugler M, Goto Y, Tamura Y, Kawamura N, Kobayashi H, Yokota T, Iwamoto C, Ohuchida K, Hashizume M, Shimizu A, Hontani H.

Int J Comput Assist Radiol Surg. 2019 Jul 2. doi: 10.1007/s11548-019-02019-8. [Epub ahead of print]

PMID:
31267332
8.

Real-time estimation of electric fields induced by transcranial magnetic stimulation with deep neural networks.

Yokota T, Maki T, Nagata T, Murakami T, Ugawa Y, Laakso I, Hirata A, Hontani H.

Brain Stimul. 2019 Jun 17. pii: S1935-861X(19)30266-9. doi: 10.1016/j.brs.2019.06.015. [Epub ahead of print]

9.

Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance.

Kumagi T, Terao T, Yokota T, Azemoto N, Kuroda T, Imamura Y, Uesugi K, Kisaka Y, Tanaka Y, Shibata N, Koizumi M, Ohno Y, Yukimoto A, Tange K, Nishiyama M, Kanemitsu K, Miyake T, Miyata H, Ishii H, Hiasa Y; Ehime Pancreato-Cholangiology (EPOCH) Study Group.

Mayo Clin Proc. 2019 Jun 28. pii: S0025-6196(19)30128-4. doi: 10.1016/j.mayocp.2018.12.034. [Epub ahead of print]

PMID:
31262521
10.

C/EBPε ΔRS derived from a neutrophil-specific granule deficiency patient interacts with HDAC1 and its dysfunction is restored by trichostatin A.

Muraoka M, Akagi T, Ueda A, Wada T, Koeffler HP, Yokota T, Yachie A.

Biochem Biophys Res Commun. 2019 Aug 13;516(1):293-299. doi: 10.1016/j.bbrc.2019.06.130. Epub 2019 Jun 27.

PMID:
31256937
11.

Highly Durable Nanofiber-Reinforced Elastic Conductors for Skin-Tight Electronic Textiles.

Jin H, Nayeem MOG, Lee S, Matsuhisa N, Inoue D, Yokota T, Hashizume D, Someya T.

ACS Nano. 2019 Jun 21. doi: 10.1021/acsnano.9b02297. [Epub ahead of print]

PMID:
31244040
12.

Intrathecal IgG Synthesis and Persistent Inflammation are Associated with White Matter Lesions in HIV-negative Patients with Cryptococcal Meningoencephalitis.

Ohyagi M, Irioka T, Ohkubo T, Ishibashi S, Takahashi YK, Amano E, Machida A, Kuwahara H, Yokota T.

Intern Med. 2019 Jun 27. doi: 10.2169/internalmedicine.2338-18. [Epub ahead of print]

13.

Detrimental Effect of Chronic Hypertension on Leptomeningeal Collateral Flow in Acute Ischemic Stroke.

Fujita K, Tanaka K, Yamagami H, Ide T, Ishiyama H, Sonoda K, Satow T, Takahashi JC, Ihara M, Koga M, Yokota T, Toyoda K.

Stroke. 2019 Jul;50(7):1751-1757. doi: 10.1161/STROKEAHA.119.025142. Epub 2019 May 16.

PMID:
31233392
14.

The efficacy and safety of nab paclitaxel plus gemcitabine in elderly patients over 75 years with unresectable pancreatic cancer compared with younger patients.

Ishimoto U, Kinoshita A, Hirose Y, Shibata K, Ishii A, Shoji R, Yokota T, Iwaku A, Mizuno Y, Koike K, Saruta M.

Cancer Chemother Pharmacol. 2019 Jun 22. doi: 10.1007/s00280-019-03895-2. [Epub ahead of print]

PMID:
31230157
15.

Ataxic phenotype with altered CaV3.1 channel property in a mouse model for spinocerebellar ataxia 42.

Hashiguchi S, Doi H, Kunii M, Nakamura Y, Shimuta M, Suzuki E, Koyano S, Okubo M, Kishida H, Shiina M, Ogata K, Hirashima F, Inoue Y, Kubota S, Hayashi N, Nakamura H, Takahashi K, Katsumoto A, Tada M, Tanaka K, Sasaoka T, Miyatake S, Miyake N, Saitsu H, Sato N, Ozaki K, Ohta K, Yokota T, Mizusawa H, Mitsui J, Ishiura H, Yoshimura J, Morishita S, Tsuji S, Takeuchi H, Ishikawa K, Matsumoto N, Ishikawa T, Tanaka F.

Neurobiol Dis. 2019 Jun 20;130:104516. doi: 10.1016/j.nbd.2019.104516. [Epub ahead of print]

PMID:
31229688
16.

Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy.

Furuta M, Yokota T, Tsushima T, Todaka A, Machida N, Hamauchi S, Yamazaki K, Fukutomi A, Kawai S, Kawabata T, Onozawa Y, Yasui H.

Jpn J Clin Oncol. 2019 Jun 20. pii: hyz089. doi: 10.1093/jjco/hyz089. [Epub ahead of print]

PMID:
31219161
17.

Highly efficient silencing of microRNA by heteroduplex oligonucleotides.

Yoshioka K, Kunieda T, Asami Y, Guo H, Miyata H, Yoshida-Tanaka K, Sujino Y, Piao W, Kuwahara H, Nishina K, Hara RI, Nagata T, Wada T, Obika S, Yokota T.

Nucleic Acids Res. 2019 Jun 19. pii: gkz492. doi: 10.1093/nar/gkz492. [Epub ahead of print]

PMID:
31214713
18.

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial.

Burtness B, Haddad R, Dinis J, Trigo J, Yokota T, de Souza Viana L, Romanov I, Vermorken J, Bourhis J, Tahara M, Martins Segalla JG, Psyrri A, Vasilevskaya I, Nangia CS, Chaves-Conde M, Kiyota N, Homma A, Holeckova P, Del Campo JM, Asarawala N, Nicolau UR, Rauch D, Even C, Wang B, Gibson N, Ehrnrooth E, Harrington K, Cohen EEW; LUX-Head & Neck 2 investigators.

JAMA Oncol. 2019 Jun 13. doi: 10.1001/jamaoncol.2019.1146. [Epub ahead of print]

PMID:
31194247
19.

A review of head and neck cancer staging system in the TNM classification of malignant tumors (eighth edition).

Head and Neck Cancer Study Group (HNCSG), Monden N, Asakage T, Kiyota N, Homma A, Matsuura K, Hanai N, Kodaira T, Zenda S, Fujii H, Tahara M, Yokota T, Akimoto T, Iwae S, Onitsuka T, Ogawa T, Okano S, Takahashi S, Shimizu Y, Yonezawa K, Hayashi R.

Jpn J Clin Oncol. 2019 Jun 13. pii: hyz052. doi: 10.1093/jjco/hyz052. [Epub ahead of print]

PMID:
31194232
20.

Development of demyelinating lesions in progressive multifocal leukoencephalopathy (PML): Comparison of magnetic resonance images and neuropathology of post-mortem brain.

Ono D, Shishido-Hara Y, Mizutani S, Mori Y, Ichinose K, Watanabe M, Tanizawa T, Yokota T, Uchihara T, Fujigasaki H.

Neuropathology. 2019 Jun 2. doi: 10.1111/neup.12562. [Epub ahead of print]

PMID:
31155757
21.

Prognostic impact of body mass index and culprit lesion calcification in patients with acute myocardial infarction.

Yokoyama H, Higuma T, Endo T, Nishizaki F, Hanada K, Yokota T, Yamada M, Okumura K, Tomita H.

Heart Vessels. 2019 May 29. doi: 10.1007/s00380-019-01439-5. [Epub ahead of print]

PMID:
31144097
22.

Amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides targeting α-synuclein as a novel therapy for Parkinson's disease.

Uehara T, Choong CJ, Nakamori M, Hayakawa H, Nishiyama K, Kasahara Y, Baba K, Nagata T, Yokota T, Tsuda H, Obika S, Mochizuki H.

Sci Rep. 2019 May 21;9(1):7567. doi: 10.1038/s41598-019-43772-9.

23.

Prevalence and clinicoradiological features of spinocerebellar ataxia type 34 in a Japanese ataxia cohort.

Ozaki K, Ansai A, Nobuhara K, Araki T, Kubodera T, Ishii T, Higashi M, Sato N, Soga K, Mizusawa H, Ishikawa K, Yokota T.

Parkinsonism Relat Disord. 2019 May 13. pii: S1353-8020(19)30241-X. doi: 10.1016/j.parkreldis.2019.05.019. [Epub ahead of print]

PMID:
31105016
24.

Selective Correction of Genotype Yield by Probucol in HDL-Deficient Mice Propagation.

Tsujita M, Akita N, Yokota T, Kobayashi F, Yokoyama S.

J Atheroscler Thromb. 2019 May 14. doi: 10.5551/jat.48967. [Epub ahead of print]

25.

Cutaneous diffuse large B-cell lymphoma mimicking rheumatoid vasculitis.

Waki D, Nishimura K, Kadoba K, Yokota T.

Rheumatology (Oxford). 2019 May 12. pii: kez193. doi: 10.1093/rheumatology/kez193. [Epub ahead of print] No abstract available.

PMID:
31081032
26.

Anti-proliferative Activities towards Human Brain Glioma U251 Cells and Human Carcinoma Cells (KB3-1) of Some Twin-Drug Type Bivalent C2-Symmetrical Phenylboronic Acid Derivatives.

Furutachi M, Gondo T, Ikeda R, Yoshikawa N, Yokota T, Takeda Y, Yokomizo K, Zhou JR, Kashige N, Miake F, Sumoto K.

Biol Pharm Bull. 2019;42(5):833-836. doi: 10.1248/bpb.b18-00859.

27.

Elevated lipid peaks during the recovery phase of Baló's concentric sclerosis: A case report.

Otsu S, Ishibashi S, Ozaki K, Yokota T.

eNeurologicalSci. 2019 Apr 9;15:100191. doi: 10.1016/j.ensci.2019.100191. eCollection 2019 Jun. No abstract available.

28.

Efficacy of Plasma Exchange in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.

Nishimura K, Waki D, Kadoba K, Mukoyama H, Yokota T, Murabe H.

Ther Apher Dial. 2019 Jun;23(3):248-252. doi: 10.1111/1744-9987.12828. Epub 2019 May 30.

PMID:
31033197
29.

Nivolumab-induced myocardial necrosis in a patient with lung cancer: A case report.

Sakai T, Yahagi K, Hoshino T, Yokota T, Tanabe K, Mori M, Ikeda S.

Respir Med Case Rep. 2019 Apr 15;27:100839. doi: 10.1016/j.rmcr.2019.100839. eCollection 2019.

30.

Cross-Sectional Area Analysis of the Head of the Caudate Nucleus in Huntington's Disease.

Furukawa F, Ishikawa K, Yokota T, Sanjo N.

Eur Neurol. 2019;81(1-2):13-18. doi: 10.1159/000499909. Epub 2019 Apr 23.

PMID:
31013498
31.

Detection of AD-specific four repeat tau with deamidated asparagine residue 279-specific fraction purified from 4R tau polyclonal antibody.

Ebashi M, Toru S, Nakamura A, Kamei S, Yokota T, Hirokawa K, Uchihara T.

Acta Neuropathol. 2019 Jul;138(1):163-166. doi: 10.1007/s00401-019-02012-0. Epub 2019 Apr 20. No abstract available.

32.

Usefulness of [11C] Methionine PET in the Differentiation of Tumefactive Multiple Sclerosis from High Grade Astrocytoma.

Hashimoto S, Inaji M, Nariai T, Kobayashi D, Sanjo N, Yokota T, Ishii K, Taketoshi M.

Neurol Med Chir (Tokyo). 2019 May 15;59(5):176-183. doi: 10.2176/nmc.oa.2018-0287. Epub 2019 Apr 17.

33.

Bi-allelic CSF1R Mutations Cause Skeletal Dysplasia of Dysosteosclerosis-Pyle Disease Spectrum and Degenerative Encephalopathy with Brain Malformation.

Guo L, Bertola DR, Takanohashi A, Saito A, Segawa Y, Yokota T, Ishibashi S, Nishida Y, Yamamoto GL, Franco JFDS, Honjo RS, Kim CA, Musso CM, Timmons M, Pizzino A, Taft RJ, Lajoie B, Knight MA, Fischbeck KH, Singleton AB, Ferreira CR, Wang Z, Yan L, Garbern JY, Simsek-Kiper PO, Ohashi H, Robey PG, Boyde A, Matsumoto N, Miyake N, Spranger J, Schiffmann R, Vanderver A, Nishimura G, Passos-Bueno MRDS, Simons C, Ishikawa K, Ikegawa S.

Am J Hum Genet. 2019 May 2;104(5):925-935. doi: 10.1016/j.ajhg.2019.03.004. Epub 2019 Apr 11.

PMID:
30982609
34.

The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of Naldemedine.

Fukumura K, Yamada T, Yokota T, Kawasaki A.

Clin Pharmacol Drug Dev. 2019 Apr 12. doi: 10.1002/cpdd.690. [Epub ahead of print]

PMID:
30977959
35.

Antisense oligonucleotides for the treatment of cardiomyopathy in Duchenne muscular dystrophy.

Nguyen Q, Yokota T.

Am J Transl Res. 2019 Mar 15;11(3):1202-1218. eCollection 2019. Review.

36.

Association between Daily Life Difficulties and Acceptance of Disability in Cancer Survivors after Total Laryngectomy: a Cross-Sectional Survey.

Teruya N, Sunagawa Y, Toyosato T, Yokota T.

Asia Pac J Oncol Nurs. 2019 Apr-Jun;6(2):170-176. doi: 10.4103/apjon.apjon_50_18.

37.

Successful treatment of a locally advanced unresectable pancreatic cancer patient with interstitial pneumonitis by conversion surgery following gemcitabine plus nab-paclitaxel chemotherapy: A case report.

Yokota T, Takano S, Yoshitomi H, Kagawa S, Furukawa K, Takayashiki T, Kuboki S, Suzuki D, Sakai N, Nojima H, Mishima T, Nakadai E, Ohtsuka M.

Mol Clin Oncol. 2019 Apr;10(4):419-424. doi: 10.3892/mco.2019.1807. Epub 2019 Feb 4.

38.

ROCK2 Regulates Monocyte Migration and Cell to Cell Adhesion in Vascular Endothelial Cells.

Takeda Y, Matoba K, Kawanami D, Nagai Y, Akamine T, Ishizawa S, Kanazawa Y, Yokota T, Utsunomiya K.

Int J Mol Sci. 2019 Mar 16;20(6). pii: E1331. doi: 10.3390/ijms20061331.

39.

Optimization of the Photon Path Length Probability Density Function-Simultaneous (PPDF-S) Method and Evaluation of CO₂ Retrieval Performance Under Dense Aerosol Conditions.

Iwasaki C, Imasu R, Bril A, Oshchepkov S, Yoshida Y, Yokota T, Zakharov V, Gribanov K, Rokotyan N.

Sensors (Basel). 2019 Mar 12;19(5). pii: E1262. doi: 10.3390/s19051262.

40.

Impaired mitochondrial oxidative phosphorylation capacity in epicardial adipose tissue is associated with decreased concentration of adiponectin and severity of coronary atherosclerosis.

Nakajima T, Yokota T, Shingu Y, Yamada A, Iba Y, Ujihira K, Wakasa S, Ooka T, Takada S, Shirakawa R, Katayama T, Furihata T, Fukushima A, Matsuoka R, Nishihara H, Dela F, Nakanishi K, Matsui Y, Kinugawa S.

Sci Rep. 2019 Mar 5;9(1):3535. doi: 10.1038/s41598-019-40419-7.

41.

Encephalopathy Induced by High Plasma and Cerebrospinal Fluid Ceftriaxone Concentrations in a Hemodialysis Patient.

Suzuki S, Naito S, Numasawa Y, Asada M, Shoji N, Zeniya M, Takahashi D, Sato H, Iimori S, Nomura N, Sohara E, Okado T, Ishiwata Y, Nagata M, Rai T, Yokota T, Uchida S.

Intern Med. 2019 Jun 15;58(12):1775-1779. doi: 10.2169/internalmedicine.1785-18. Epub 2019 Feb 25.

42.

[The Immune Checkpoints Inhibitors for Head and Neck Cancer].

Yokota T.

Gan To Kagaku Ryoho. 2019 Jan;46(1):21-27. Japanese.

PMID:
30765636
43.

Scavenger Receptor Class A1 Mediates Uptake of Morpholino Antisense Oligonucleotide into Dystrophic Skeletal Muscle.

Miyatake S, Mizobe Y, Tsoumpra MK, Lim KRQ, Hara Y, Shabanpoor F, Yokota T, Takeda S, Aoki Y.

Mol Ther Nucleic Acids. 2019 Mar 1;14:520-535. doi: 10.1016/j.omtn.2019.01.008. Epub 2019 Jan 25.

44.

Diastolic Intra-Left Ventricular Pressure Difference During Exercise: Strong Determinant and Predictor of Exercise Capacity in Patients With Heart Failure.

Tsujinaga S, Iwano H, Sarashina M, Hayashi T, Murayama M, Ichikawa A, Nakabachi M, Nishino H, Yokoyama S, Fukushima A, Yokota T, Okada K, Kaga S, Vlachos PP, Anzai T.

J Card Fail. 2019 Apr;25(4):268-277. doi: 10.1016/j.cardfail.2019.02.005. Epub 2019 Feb 10.

PMID:
30753935
45.

[Severe interstitial lung disease after one cycle of nivolumab treatment in a patient with advanced gastric cancer].

Shimada S, Ando T, Yokota T, Sakumura M, Yoshita H, Nanjo S, Mihara H, Kajiura S, Fujinami H, Yasuda I.

Nihon Shokakibyo Gakkai Zasshi. 2019;116(2):153-160. doi: 10.11405/nisshoshi.116.153. Japanese.

PMID:
30745553
46.

Outcomes After Aortic Valve Replacement for Asymptomatic Severe Aortic Regurgitation and Normal Ejection Fraction.

Maeda S, Taniguchi K, Toda K, Funatsu T, Kondoh H, Yokota T, Kainuma S, Daimon T, Yoshikawa Y, Sawa Y; Osaka Cardiovascular Surgery Research (OSCAR) Group.

Semin Thorac Cardiovasc Surg. 2019 Feb 5. pii: S1043-0679(19)30024-3. doi: 10.1053/j.semtcvs.2019.02.005. [Epub ahead of print]

PMID:
30731192
47.

The Embryonic Stem Cell-Specific Transcription Factor ZFP57 Promotes Liver Metastasis of Colorectal Cancer.

Shoji Y, Takamura H, Ninomiya I, Fushida S, Tada Y, Yokota T, Ohta T, Koide H.

J Surg Res. 2019 May;237:22-29. doi: 10.1016/j.jss.2018.11.014. Epub 2019 Jan 22.

PMID:
30694787
48.

Facile preparation of optically active jasmonates and their biological activities in rice.

Miyamoto K, Matsumoto T, Yumoto E, Sakazawa T, Yokota T, Yamane H, Uchida K.

Biosci Biotechnol Biochem. 2019 May;83(5):876-881. doi: 10.1080/09168451.2019.1569500. Epub 2019 Jan 24.

PMID:
30676297
49.

Artificial cationic peptides that increase nuclease resistance of siRNA without disturbing RNAi activity.

Maeda Y, Iwata Hara R, Nishina K, Yoshida-Tanaka K, Sakamoto T, Yokota T, Wada T.

Nucleosides Nucleotides Nucleic Acids. 2019;38(5):338-348. doi: 10.1080/15257770.2018.1543890. Epub 2019 Jan 19.

PMID:
30663497
50.

Safety and efficacy of concurrent carboplatin or cetuximab plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.

Hamauchi S, Yokota T, Mizumachi T, Onozawa Y, Ogawa H, Onoe T, Kamijo T, Iida Y, Nishimura T, Onitsuka T, Yasui H, Homma A.

Int J Clin Oncol. 2019 May;24(5):468-475. doi: 10.1007/s10147-018-01392-9. Epub 2019 Jan 17.

PMID:
30656463

Supplemental Content

Loading ...
Support Center